501 related articles for article (PubMed ID: 25327941)
21. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
22. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model.
Pflug BR; Pecher SM; Brink AW; Nelson JB; Foster BA
Prostate; 2003 Nov; 57(3):245-54. PubMed ID: 14518031
[TBL] [Abstract][Full Text] [Related]
23. Metastatic prostate cancer in a transgenic mouse.
Gingrich JR; Barrios RJ; Morton RA; Boyce BF; DeMayo FJ; Finegold MJ; Angelopoulou R; Rosen JM; Greenberg NM
Cancer Res; 1996 Sep; 56(18):4096-102. PubMed ID: 8797572
[TBL] [Abstract][Full Text] [Related]
24. Tumor suppressor RKIP inhibits prostate cancer cell metastasis and sensitizes prostate cancer cells to docetaxel treatment.
Zhu CX; Li WZ; Guo YL; Chen L; Li GH; Yu JJ; Shu B; Peng S
Neoplasma; 2018; 65(2):228-233. PubMed ID: 29534584
[TBL] [Abstract][Full Text] [Related]
25. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.
Foster BA; Gingrich JR; Kwon ED; Madias C; Greenberg NM
Cancer Res; 1997 Aug; 57(16):3325-30. PubMed ID: 9269988
[TBL] [Abstract][Full Text] [Related]
26. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model.
Li X; Yokoyama NN; Zhang S; Ding L; Liu HM; Lilly MB; Mercola D; Zi X
Oncotarget; 2015 Dec; 6(39):41809-24. PubMed ID: 26497688
[TBL] [Abstract][Full Text] [Related]
27. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
Raghow S; Kuliyev E; Steakley M; Greenberg N; Steiner MS
Cancer Res; 2000 Aug; 60(15):4093-7. PubMed ID: 10945615
[TBL] [Abstract][Full Text] [Related]
28. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice.
Williams TM; Hassan GS; Li J; Cohen AW; Medina F; Frank PG; Pestell RG; Di Vizio D; Loda M; Lisanti MP
J Biol Chem; 2005 Jul; 280(26):25134-45. PubMed ID: 15802273
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
30. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.
Minoo P; Zlobec I; Baker K; Tornillo L; Terracciano L; Jass JR; Lugli A
Am J Clin Pathol; 2007 May; 127(5):820-7. PubMed ID: 17439843
[TBL] [Abstract][Full Text] [Related]
31. Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene.
Keller ET; Fu Z; Yeung K; Brennan M
Cancer Lett; 2004 Apr; 207(2):131-7. PubMed ID: 15151133
[TBL] [Abstract][Full Text] [Related]
32. Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer.
Woods Ignatoski KM; Grewal NK; Markwart SM; Vellaichamy A; Chinnaiyan AM; Yeung K; Ray ME; Keller ET
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):153-60. PubMed ID: 18722266
[TBL] [Abstract][Full Text] [Related]
33. RKIp inhibits the migration and invasion of human prostate cancer PC-3M cells through regulation of extracellular matrix.
Xinzhou H; Ning Y; Ou W; Xiaodan L; Fumin Y; Huitu L; Wei Z
Mol Biol (Mosk); 2011; 45(6):1004-11. PubMed ID: 22295570
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.
Wikström P; Lindahl C; Bergh A
Prostate; 2005 Feb; 62(2):148-64. PubMed ID: 15389804
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
Wu GJ; Fu P; Chiang CF; Huss WJ; Greenberg NM; Wu MW
J Urol; 2005 May; 173(5):1778-83. PubMed ID: 15821586
[TBL] [Abstract][Full Text] [Related]
36. Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management.
Ghosh R; Graham H; Rivas P; Tan XJ; Crosby K; Bhaskaran S; Schoolfield J; Banu J; Fernandes G; Yeh IT; Kumar AP
Anticancer Res; 2010 Mar; 30(3):857-65. PubMed ID: 20393007
[TBL] [Abstract][Full Text] [Related]
37. Differential requirement for Src family tyrosine kinases in the initiation, progression, and metastasis of prostate cancer.
Gelman IH; Peresie J; Eng KH; Foster BA
Mol Cancer Res; 2014 Oct; 12(10):1470-9. PubMed ID: 25053806
[TBL] [Abstract][Full Text] [Related]
38. Glutathione Peroxidase 3 Inhibits Prostate Tumorigenesis in TRAMP Mice.
Chang SN; Lee JM; Oh H; Park JH
Prostate; 2016 Nov; 76(15):1387-98. PubMed ID: 27325372
[TBL] [Abstract][Full Text] [Related]
39. Gene expression signatures associated with suppression of TRAMP prostate carcinogenesis by a kavalactone-rich Kava fraction.
Tang SN; Zhang J; Jiang P; Datta P; Leitzman P; O'Sullivan MG; Jiang C; Xing C; Lü J
Mol Carcinog; 2016 Dec; 55(12):2291-2303. PubMed ID: 26840761
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction.
Baritaki S; Chapman A; Yeung K; Spandidos DA; Palladino M; Bonavida B
Oncogene; 2009 Oct; 28(40):3573-85. PubMed ID: 19633685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
